GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALPL, AR, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
8.14407 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA |
7.57056 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, RORC, SLC6A4, SRC, TYR |
7.47097 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GPER1, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SLC6A4, SRC, TYR |
7.21039 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, CYP1B1, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SLC6A4, SRC, TERT, XDH |
6.99182 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALPL, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SLC6A4, SRC, TYR |
6.92933 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, RORC, SRC |
6.90349 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD17B1, HSD17B2 |
6.77373 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
6.75106 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, AR, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, PPARA, SLC6A4, SRC |
6.24058 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, AR, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KCNH2, KDR, MMP2, MMP9, RORC, SLC6A4, SRC, TERT |
6.24058 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH |
6.19023 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
6.19023 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FUT7, PIM1, PPARA, TYR, XDH |
5.99954 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
5.92315 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, GPER1, RORC, SLC6A4, SRC, TYR |
5.81224 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, AR, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, SLC6A4, SRC |
5.81224 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AR, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, FABP4, GPER1, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TYR |
5.63317 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.62589 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, TYR, XDH |
5.56124 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GPER1, HSD17B1, HSD17B2, KCNH2, KDR, MET, PPARA, SLC6A2, SLC6A4, SRC, TERT, XDH |
5.30037 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
5.2893 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.28038 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.06857 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
4.93658 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GPER1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.91701 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GPER1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.91605 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.91605 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, ESR1, FLT3, GPER1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
4.84811 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.82599 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
4.80734 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALPL, AR, AURKB, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD17B2, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
4.79783 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
4.78773 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.70154 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, AR, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, MMP2, RORC, SLC6A4, SRC |
4.68694 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.54318 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.54134 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, AR, CYP1A1, CYP1B1, ESR1, FLT3, GPER1, RORC, SLC6A4, SRC |
4.53371 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
4.53275 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, MET, PPARA |
4.46441 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC, TERT |
4.46046 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, AR, AURKB, AXL, CA2, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A4, SRC, TERT, TYR |
4.3955 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, IGF1R, KCNH2, KDR, MMP2, MMP9, PTPN1, RORC, SLC6A4, SRC, TERT |
4.34322 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
4.30188 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT |
4.24207 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
4.22301 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
4.18518 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, GPER1, HSD17B1, HSD17B2 |
4.11597 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TYR, XDH |
3.92525 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.92525 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.92407 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.89559 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GPER1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
3.78625 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.78538 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.77835 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.77835 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.72995 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.65633 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
3.6072 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, CSNK2A1, CYP1B1, FLT3, GPER1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
3.58075 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SLC6A4, SRC, TERT, XDH |
3.57495 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, GPER1, PPARA, RORC, SRC |
3.57495 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, GPER1, KCNH2, MET, SRC, TERT |
3.50726 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, TYR, XDH |
3.42042 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AR, AXL, CYP1B1, ESR1, GPER1, IGF1R, MMP2, MMP9, RORC, SLC6A4, SRC |
3.41257 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.39684 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, CSNK2A1, CYP1B1, ESRRA, FABP4, FLT3, GPER1, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, XDH |
3.3409 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.34047 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.33265 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.32777 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
3.32412 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.30299 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CES1, CYP1A1, CYP1B1, KDR, SLC6A4, SRC |
3.27421 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.23552 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TYR, XDH |
3.18572 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
3.16635 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
3.11986 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.1065 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, AR, CYP19A1, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
3.10209 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.1008 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, CYP1B1, FLT3, GPER1, KDR, MET, PTPN1, SRC, XDH |
3.1008 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, GPER1, MMP9 |
3.0973 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR |
3.02022 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, GPER1, MMP9 |
3.01518 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
GPER1, MMP2, MMP9, TERT |
3.01518 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.00005 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.95097 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.91795 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AR, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.89557 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.83359 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.83143 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.81126 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, ESR1, FLT3, GPER1, RORC, SLC6A4, SRC |
2.80969 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.80325 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
2.77049 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.75553 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.67956 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.67568 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.65451 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.65139 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, AR, CDC25B, ESRRB, FABP3, FLT3, GPER1, KDR, MMP9, PTPN1, SRC, XDH |
2.63221 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, AR, CDC25B, ESRRB, FABP3, FLT3, GPER1, KDR, MMP9, PTPN1, SRC, XDH |
2.63221 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CYP19A1, ESR1, FABP4, GPER1, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, SRC, TERT, XDH |
2.62446 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.62151 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.6097 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.6097 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, AR, FLT3, GPER1, KDR, PTPN1, SRC, XDH |
2.59973 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.58894 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.56341 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.56341 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.56341 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, PPARA, RORC, SLC6A4, SRC |
2.56341 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, CA2, CYP19A1, GPER1, KCNH2, MMP12, SLC6A4, SRC, TERT |
2.55225 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, AR, CDC25B, ESRRB, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.51962 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.50383 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.46301 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46301 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, AR, CDC25B, ESRRB, FLT3, GPER1, KDR, MMP9, PTPN1, SRC, XDH |
2.45723 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, AR, ESR1, FLT3, GPER1, IGF1R, MMP2, SLC6A4, SRC |
2.43505 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, PPARA, RORC, SRC |
2.42566 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, AR, CDC25B, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.42566 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA |
2.41928 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, FABP4, FLT3, GPER1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TERT, XDH |
2.41533 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AR, AXL, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, SLC6A4, SRC |
2.41533 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, MET, MMP9, PPARA, SRC, TERT |
2.40778 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.40107 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, AR, CDC25B, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.39816 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, GPER1, SLC6A4 |
2.39434 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.39201 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, GPER1, KDR, SRC |
2.38501 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.38501 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD17B1, HSD17B2 |
2.37084 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, AR, AXL, CA2, CYP1B1, ESR1, ESRRA, ESRRB, GPER1, KCNH2, KDR, MET, MMP12, MMP9, PIM1, SLC6A4, SRC, TERT, XDH |
2.37065 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.36276 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.36276 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.36064 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, GPER1, MMP2, MMP9, TERT |
2.35007 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.3211 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.31247 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, AR, FLT3, GPER1, IGF1R, KDR, PTPN1, SRC, XDH |
2.30324 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, SLC6A4, SRC |
2.29682 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, GPER1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.29625 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, CA2, FLT3, GPER1, SRC |
2.2908 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TERT |
2.26925 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26925 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.26222 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GPER1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.25797 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25214 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.25214 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25214 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CYP1A1, CYP1B1, FABP3, KCNH2, KDR, SLC6A2, SLC6A4, SRC |
2.24435 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, GPER1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.21657 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, SRC |
2.18734 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.16734 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, CA2, CA7, CYP19A1, GPER1, KCNH2, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
2.16183 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, SRC |
2.14839 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, GPER1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.1442 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TERT |
2.14224 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, FABP3, FLT3, GPER1, IGF1R, MMP2, PPARA, SLC6A4, SRC, TYR |
2.14224 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, GPER1, KDR, SRC |
2.1248 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.11343 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.08636 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, CA12, CA2, CA7, ESR1, FABP3, FABP4, GPER1, KCNH2, MET |
2.05547 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.05381 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, GPER1, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.05336 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, AR, CDC25B, FLT3, GPER1, KDR, MMP9, PTPN1, SRC, XDH |
2.05336 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.04863 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, GPER1, MMP12, MMP2, PPARA, PTPN1, SRC |
2.03693 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, GPER1, SLC6A4, SRC |
2.03575 |
[BP] GO:0035265 |
organ growth
|
AR, CYP19A1, ESR1 |
2.03575 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.02738 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GPER1, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
2.01044 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, MET, MMP12, PPARA, PTPN1, RORC, SRC, TERT |
2.00025 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.94793 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPL, AR, AXL, CA12, CA14, CA2, CA4, CSNK2A1, ESR1, FLT3, GPER1, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT |
1.84205 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, AR, AURKB, AXL, CA1, CA2, CA4, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GPER1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SHBG, SRC, TERT, TYR, XDH |
1.70631 |
[CC] GO:0005783 |
None
|
ADORA1, CA4, CES1, CES2, CYP19A1, FLT3, GPER1, KDR, PTPN1, XDH |
1.57101 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AR, AURKB, CA1, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GPER1, HSD17B1, HSD17B2, KCNH2, KDR, MMP2, MMP9, PIM1, PTPN1, SLC6A4, SRC, TERT, TYR, XDH |
1.50365 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
14.2642 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
8.11324 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
8.11324 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
8.04772 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.04772 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, RORC, SHBG |
7.97811 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.73239 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TYR, XDH |
7.25118 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
6.86937 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
6.18201 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
5.81195 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.09016 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
4.91605 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HSD17B1, PPARA, RORC, SHBG |
4.5498 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.46441 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
4.36202 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, TYR, XDH |
4.26572 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, HSD17B1, IGF1R, SHBG |
4.20321 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.16188 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.10963 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
4.08637 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.95372 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
3.92407 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.78619 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.59938 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.57495 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
3.46045 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.33265 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
3.31685 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
3.20973 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.18122 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.14297 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
3.00005 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A4, SRC |
2.95716 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
2.95097 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.83359 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.83359 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, SRC, XDH |
2.74818 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MMP9, SLC6A4, TERT, TYR, XDH |
2.68976 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.63221 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.6097 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.6097 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.56341 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.46301 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.46301 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.44873 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25214 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.25214 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.25214 |
[MF] GO:0052689 |
carboxylic ester hydrolase activity
|
ACHE, CA1, CA2, CES1, CES2 |
2.17992 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.04863 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.00025 |